Citation Impact
Citing Papers
Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS
2014
An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori
2000
Functional bowel disorders and functional abdominal pain
1999 Standout
Is bran efficacious in irritable bowel syndrome? A double blind placebo controlled crossover study.
1987
Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study
1998
Discriminant value of dyspeptic symptoms: a study of the clinical presentation of 221 patients with dyspepsia of unknown cause, peptic ulceration, and cholelithiasis.
1987
Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification
1999 Standout
The role of bile acids in functional GI disorders
2014
Some diseases characteristic of modern Western civilization.
1973
Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome
2011
Postnatal Deletion of Fat Storage-inducing Transmembrane Protein 2 (FIT2/FITM2) Causes Lethal Enteropathy
2015
Bile acid transporters
2009
The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism
2013 Standout
Antidepressant therapy in 138 patients with irritable bowel syndrome: a five‐year clinical experience
1994
Intestinal Microbiota And Diet in IBS: Causes, Consequences, or Epiphenomena?
2015
Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions
2010
Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients
2007
Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
2013 Standout
Functional Bowel Disorders
2006 Standout
Cure of duodenal ulcer associated with eradication of Helicobacter pylori
1990 Standout
Classification and Grading of Gastritis
1996 Standout
Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome
2004
Modulation of Protein Fermentation Does Not Affect Fecal Water Toxicity: A Randomized Cross-Over Study in Healthy Subjects
2012
Non-invasive quantification of small bowel water content by MRI: a validation study
2007
Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome
2009
Functional Gastroduodenal Disorders
2006 Standout
Bowel Disorders
2016 Standout
Wearable biosensors for healthcare monitoring
2019 Standout
Brain–Gut Microbiome Interactions and Functional Bowel Disorders
2014
Basal gastric acid secretion in nonulcer dyspepsia with or without duodenitis
1989
Placebo-controlled comparison of piroxicam-?-cyclodextrin, piroxicam, and indomethacin on gastric potential difference and mucosal injury in humans
1992
Management of the irritable bowel syndrome
2001
The gut microbiota, bacterial metabolites and colorectal cancer
2014 Standout
Accurate enzymatic measurement of fecal bile acids in patients with malabsorption
2003
Estimation of the fermentability of dietary fibrein vitro: a European interlaboratory study
1995
Dietary fiber, inulin, and oligofructose: A review comparing their physiological effects
1993
The Human Intestinal Microbiome in Health and Disease
2016 Standout
Is untargeted outreach visiting in primary care effective? A pragmatic randomized controlled trial
2001
Saliva as a diagnostic fluid
2002
Helicobacter pylori infection among Japanese children
2000
A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
1997 Standout
The Effect of Starch Malabsorption on Fecal Short-Chain Fatty Acid Excretion in Man
1988
The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders
2007 Standout
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial
2000 Standout
Irritable bowel syndrome
2016 Standout
Controlled treatment trials in the irritable bowel syndrome: A critique
1988
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
2000 Standout
British Dietetic Association evidence‐based guidelines for the dietary management of irritable bowel syndrome in adults
2012
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
Dietary treatment of irritable bowel syndrome: current evidence and guidelines for future practice
2001
What is behind dyspepsia?
1993
The Functional Gastrointestinal Disorders and the Rome III Process
2006 Standout
A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome
2013 Standout
Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications?
2002 Standout
Peripheral Mechanisms in Irritable Bowel Syndrome
2012
Basic and clinical aspects of visceral hyperalgesia
1994
Dynamics and functions of lipid droplets
2018 Standout
A Placebo-Controlled, Double-Blind, Randomized Trial of Cyclosporine Therapy in Active Chronic Crohn's Disease
1989
Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics
1995 Standout
Is the Irritable Gut an Inflamed Gut?
1992
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
Systematic review: the efficacy of treatments for irritable bowel syndrome – a European perspective
2006
Diet rapidly and reproducibly alters the human gut microbiome
2013 StandoutNature
Maintenance Ranitidine Treatment after Haemorrhage from a Duodenal Ulcer: A 3-Year Study
1988
Lansoprazole in the treatment of functional dyspepsia: Two Double-Blind, Randomized, Placebo-Controlled trials
2004
Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis
2000
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome as Well as Traditional Dietary Advice: A Randomized Controlled Trial
2015 Standout
Peppermint Oil for Irritable Bowel Syndrome: A Critical Review and Metaanalysis
1998
The Irritable Bowel Syndrome: Mechanisms and a Practical Approach to Management
1992
Cyclodextrin-based pharmaceutics: past, present and future
2004 Standout
Fecal Short-Chain Fatty Acids in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: In Vitro Studies of Carbohydrate Fermentation
1996
Sexual and Physical Abuse in Women with Functional or Organic Gastrointestinal Disorders
1990 Standout
Reflux Esophagitis
1990
Colonic Fermentation of Ispaghula, Wheat Bran, Glucose, and Albumin to Short‐Chain Fatty Acids and Ammonia Evaluated in Vitro in 50 Subjects
1992
Effect of dietary fiber on symptoms and rectosigmoid motility in patients with irritable bowel syndrome
1990
Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota
1997 Standout
Bleeding Peptic Ulcer
1994 Standout
Inflammatory bowel disease: Etiology and pathogenesis
1998 Standout
AGA technical review on irritable bowel syndrome
2002 Standout
Fermentation to Short-Chain Fatty Acids and Lactate in Human Faecal Batch Cultures Intra- and Inter-Individual Variations versus Variations Caused by Changes in Fermented Saccharides
1991
The prevalence and clinical course of functional dyspepsia
2004
Cervical cancer
2019 Standout
A Patient Questionnaire to Identify Bowel Disease
1989 Standout
Intestinal absorption of bile acids in the pig
1988
Comparison of Diarrhea Induced by Ingestion of Fructooligosaccharide Idolax and Disaccharide Lactulose (Role of Osmolarity Versus Fermentation of Malabsorbed Carbohydrate)
1998
Effect of Human Faecal Donor on in Vitro Fermentation Variables
1989
Bran supplementation in the treatment of irritable bowel sgndrome
1994
The human microbiome: at the interface of health and disease
2012 Standout
Comparison of the effects of medium and long chain triglyceride containing liquid meals on gall bladder and small intestinal function in normal man.
1984
Irritable Bowel Syndrome
2015 Standout
Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome
2012
Audit and feedback: effects on professional practice and healthcare outcomes
2012 Standout
DIFFERENCE IN RELAPSE RATES OF DUODENAL ULCER AFTER HEALING WITH CIMETIDINE OR TRIPOTASSIUM DICITRATO BISMUTHATE
1981
Short-Chain Fatty Acids and Human Colonic Function: Roles of Resistant Starch and Nonstarch Polysaccharides
2001 Standout
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Cimetidine for Severe Gastroduodenal Haemorrhage: A Randomized Controlled Trial
1980
The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota
2013
Double blind study of ispaghula in irritable bowel syndrome.
1987
Intestinal microbiota in human health and disease: the impact of probiotics
2011
Effect of Substrate Concentration on Short Chain Fatty Acid Production inIn vitroCultures of Human Faeces with Lactulose, a Rapidly Fermented Carbohydrate
2002
Cyclodextrin Drug Carrier Systems
1998 Standout
Efficacy of omeprazole in functional dyspepsia: double‐blind, randomized, placebo‐controlled trials (the Bond and Opera studies)
1998
Loperamide in Treatment of Irritable Bowel Syndrome—A Double-Blind Placebo Controlled Study
1987
Association of anxiety, neuroticism, and depression with dyspepsia of unknown cause
1986
Prognosis of Chronic Unexplained Dyspepsia
1987
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Pharmacologic Treatment of the Irritable Bowel Syndrome
2000
The Association between Non-Ulcer Dyspepsia and Other Gastrointestinal Disorders
1985
Mitral Valvular Disease
1972
Physical and psychological evaluation of 'non-organic' abdominal pain.
1967
Gastroduodenitis
1980
Subepithelial hemorrhages and erosions of human stomach
1988
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
Treatment with Histamine H2Antagonists in Acute Upper Gastrointestinal Hemorrhage
1985 Standout
Terminal ileal mucosal mast cells in irritable bowel syndrome
1993
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
A critical review of cyclosporine therapy in inflammatory bowel disease
1995
UNIDENTIFIED CURVED BACILLI IN THE STOMACH OF PATIENTS WITH GASTRITIS AND PEPTIC ULCERATION
1984 Standout
Clinical presentation of patients with "dyspepsia". Detailed symptomatic study of 360 patients.
1978
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
2016 Standout
Complexity and contradiction in clinical trial research
1987
Works of E Krag being referenced
Effect of enterocoated cholestyramine on bowel habit after ileal resection: a double blind crossover study.
1985
Prophylactic effect of cimetidine in duodenal ulcer disease.
1978
Bile Acids in Health and Disease
1996
Low‐dose cyclosporin for Crohn's disease: implications for clinical trials
1989
The effect of IV indomethacin on the gastric mucosal electrical potential difference and blood flow in anaesthetized dogs
1988
Longitudinal Study of Influence ofHelicobacter pylorion Current Risk of Duodenal Ulcer Relapse
1992
A New Method for Measurement of the Electrical Potential Difference across the Stomach Wall: Clinical Evaluation of the Gastric Mucosal Integrity
1987
Cimetidine in patients with gastric ulcer: a multicentre controlled trial.
1977
Effect of free and conjugated bile acids on net water, electrolyte, and glucose movement in the perfused human ileum.
1974
The pseudo-ulcer syndrome. A clinical, radiographic and statistical follow-up study of patients with ulcer symptoms but no demonstrable ulcer in the stomach or duodenum.
1969
Relationships between Ion and Water Movement in the Human Jejunum, Ileum and Colon during Perfusion with Bile Acids
1973
Antisecretory Therapy in 1017 Patients with Ulcerlike or Refluxlike Dyspepsia in General Practice
1997
Pseudo-ulcer and true peptic ulcer. A clinical, radiographic and statistical follow-up study.
1965
Non-ulcer dyspepsia introduction: epidemiological data.
1982
Pseudo‐ulcer and True Peptic Ulcer
1965
Chronic ischemic gastritis reversed after revascularization operation
1987
A Secretory Epithelium of the Small Intestine with Increased Sensitivity to Bile Acids in Irritable Bowel Syndrome Associated with Diarrhoea
1978
Enlarged Gastric and Duodenal Rugae
1966
Regional ileitis (Crohn's disease). I. Kinetics of bile acid absorption in the perfused ileum.
1976
Irritable Bowel Syndrome: Current Concepts and Future Trends
1985
Short-Chain Fatty Acids and the Irritable Bowel Syndrome: The Effect of Wheat Bran
1987
The Effect of Coarse Wheat Bran in the Irritable Bowel Syndrome lA Double-Blind Cross-Over Study
1985
The Influence of Ispaghula Husk and Lactulose on the In Viva and the In Vitro Production Capacity of Short-Chain Fatty Acids in Humans
1987
The Normal Gastric and Duodenal Rugae
1967
Active and Passive Bile Acid Absorption in Man. PERFUSION STUDIES OF THE ILEUM AND JEJUNUM
1974
Effect of Glycochenodeoxycholic Acid on Unidirectional Transepithelial Fluxes of Electrolytes in the Perfused Human Ileum
1977
A Comparison of Stable and 3H-Labelled Polyethylene Glycol 4000 as Non-Absorbable Water Phase Markers in the Human Ileum and Faeces
1975
Enzymatic Determination of Total 3α-Hydroxy Bile Acids in Faeces
1982
Reply
1987
Regional Ileitis (Crohn’s Disease)
1976
A secretory epithelium of the small intestine with increased sensitivity to bile acids in irritable bowel syndrome associated with diarrhoea.
1978